Merck's anti-clotting drug flops in key trial aimed at preventing heart attacks, strokes

ORLANDO, Fla. - A blood thinner being developed by Merck has flopped in a major study aimed at preventing heart attacks, strokes and other problems in people who had suffered a heart attack or severe chest pain from clogged arteries....More